10-K Decoder · All companies

Jazz Pharmaceuticals plc

JAZZ · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Feb 2026

Open the dashboardInfographicSummary

FY2025 key figures

$FY2025FY2024Change
Revenue$4.27B$4.07B+4.9%
Operating income−$430M$717M
Net income−$356M$560M

Latest quarter: Q3 2026

Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 2, 2026

$Q3 2026Year earlierChange
Revenue$1.24B$1.13B+10.4%
Operating income−$413M$57.5M
Net income−$483M$251M

Q3 2026 dashboardQ3 2026 infographic

Questions

What was Jazz Pharmaceuticals's revenue in FY2025?
$4.27B in FY2025 (Fiscal year ended Dec 31, 2025), +4.9% vs $4.07B a year earlier, per its 10-K filed Feb 2026.
Was Jazz Pharmaceuticals profitable in FY2025?
No: net income was −$356M and operating income −$430M in FY2025.
What was Jazz Pharmaceuticals's revenue in Q3 2026?
$1.24B (+10.4% vs a year earlier), per its Form 10-Q filed Nov 2, 2026.